```html

Wischnewski Spots (Gastric Mucosal Lesions): A Patient‑Friendly Guide

Overview

Wischnewski spots, also written as Wischnewsky spots, are distinct, well‑demarcated, black‑brown or grayish‑white lesions that appear on the gastric mucosa. They were first described in 1884 by the German physician Georg Wischnewsky in patients who had died from severe vomiting associated with acute hemorrhagic gastritis.

These lesions are most commonly seen in the setting of acute severe gastro‑intestinal stress such as:

• Massive or prolonged vomiting (e.g., due to pyloric obstruction, bulimia, or neuro‑gastric dysregulation)
• Severe metabolic derangements—especially profound hypokalemia, hypochloremia, and metabolic alkalosis
• Critical illness states (sepsis, major trauma, burns) that produce “stress gastritis”

Although historically linked to “bulimia‑type” vomiting, modern data indicate that Wischnewski spots are a relatively rare finding, identified in 1–5 % of patients undergoing upper endoscopy for acute vomiting or severe electrolyte disturbance.<sup>[1] Mayo Clinic 2023</sup> They are seen in both sexes, but a slight male predominance has been reported because “bulimic” behavior (which is more common in women) does not always produce the classic spots; instead, they are more frequent in men with alcohol‑related vomiting or traumatic injury.

Symptoms

Wischnewski spots themselves are not painful and rarely cause symptoms directly. The clinical picture is driven by the underlying condition that precipitates the lesions. Below is a comprehensive symptom list, grouped by the most common precipitating disorders.

1. Symptoms related to severe vomiting

• Recurrent, forceful emesis – may be bright‑red (blood‑tinged) or clear.
• Epigastric or retro‑sternal burning – from acid exposure.
• Halitosis – “sour” breath from retained gastric contents.
• Dry mouth, thirst, and dehydration.

2. Electrolyte‑disturbance symptoms

• Muscle cramps, weakness, or paresthesias – hallmark of hypokalemia.
• Palpitations or arrhythmias – may present as skipped beats, racing heart, or faintness.
• Confusion, lethargy, or seizures in severe cases.

3. Systemic stress‑related symptoms

• Fever, chills, or rigors – often when the underlying cause is infection or sepsis.
• Abdominal tenderness or guarding – can signal concurrent gastric ulceration or perforation.
• Chest discomfort – may be mistaken for cardiac pain; always evaluate.

4. Red‑flag symptoms that suggest complications

• Vomiting bright red blood (hematemesis) or coffee‑ground material.
• Severe abdominal pain sudden in onset.
• Unexplained dizziness, syncope, or sudden drop in blood pressure.

Causes and Risk Factors

Primary Mechanism

The exact pathophysiology is not fully understood, but most experts agree that Wischnewski spots result from ischemic necrosis of superficial gastric mucosal cells combined with pigment deposition from oxidized hemoglobin and melanin‑like substances. The lesions become visible after the mucosa is exposed to gastric acid following massive vomiting, which creates a highly alkaline environment in the stomach (due to loss of HCl) that facilitates pigment formation.

Major Triggers

• Prolonged or cyclic vomiting – >6 hours of continuous emesis or >3 episodes per day for several days.
• Severe electrolyte abnormalities – potassium < 2.5 mmol/L, chloride < 90 mmol/L, and pH >7.55 (metabolic alkalosis).
• Acute stress gastritis – ICU patients, major burns, or trauma.
• Alcoholic binge drinking – especially when accompanied by vomiting.
• Bulimia nervosa – chronic self‑induced vomiting.

Risk Factors

• Age 15–45 years – the age group most likely to engage in binge‑purge behavior.
• Male sex – higher incidence in trauma‑related vomiting.
• History of electrolyte disorders or chronic diuretic use.
• Use of pro‑kinetic or anti‑emetic medications that do not correct the underlying metabolic loss.
• Concurrent use of non‑steroidal anti‑inflammatory drugs (NSAIDs) – predispose to mucosal injury.

Diagnosis

Clinical suspicion

Because Wischnewski spots are visual findings, the diagnosis is usually made during an upper gastrointestinal (GI) endoscopy (esophagogastroduodenoscopy, EGD) performed for evaluation of severe vomiting, GI bleeding, or unexplained abdominal pain.

Endoscopic appearance

• Multiple, discrete, flat or slightly raised lesions.
• Color: dark brown to black, sometimes with a whitish rim.
• Location: predominantly in the gastric antrum and body, sparing the fundus.
• Size: usually 2–5 mm, but larger confluent patches can occur.

Histopathology (when biopsied)

Biopsy is rarely needed, but if performed, pathology shows:

• Superficial mucosal necrosis with pigment‑laden macrophages.
• Absence of dysplasia or malignant cells.
• Iron‑positive staining (Prussian blue) may be present due to hemosiderin.

Ancillary tests

• Serum electrolytes – potassium, chloride, bicarbonate, magnesium.
• Arterial blood gas (ABG) – to quantify metabolic alkalosis.
• Complete blood count (CBC) – look for anemia from occult bleeding.
• Stool occult blood – if GI bleeding is suspected.
• Imaging (CT abdomen) – reserved for patients with suspected perforation or intra‑abdominal abscess.

Treatment Options

1. Correct the underlying metabolic disturbance

• Potassium repletion – intravenous (IV) potassium chloride 20–40 mEq/hr (max 100 mEq/24 h) with cardiac monitoring.
• Chloride replacement – isotonic saline bolus (1–2 L) as needed.
• Acid‑base correction – careful administration of dilute HCl (e.g., 0.5 N) in severe alkalosis, guided by ABG trends.

2. Symptomatic management of vomiting

• Antiemetics – Ondansetron 4–8 mg IV/PO q8h, or Metoclopramide 10 mg IV q6h.
• Proton‑pump inhibitors (PPIs) – Omeprazole 40 mg IV daily or Pantoprazole 40 mg IV daily to reduce gastric acid secretion and allow mucosal healing.
• Hydration – Isotonic crystalloid fluids (e.g., Lactated Ringer’s) to restore intravascular volume.

3. Endoscopic therapy (rare)

In cases where lesions are large, bleed, or ulcerate, endoscopic hemostasis (epinephrine injection, coagulation forceps, or clips) may be required. However, most Wischnewski spots are self‑limited once the precipitating factor is removed.

4. Long‑term pharmacologic strategies

• Maintenance PPI therapy (e.g., Omeprazole 20 mg daily) for 4–6 weeks if gastritis persists.
• Consider H2‑blockers (Ranitidine 150 mg BID) if PPIs are contraindicated.
• Electrolyte‑balancing agents – oral potassium chloride (20 mEq) once serum levels stabilize.

5. Lifestyle and psychosocial interventions

• Referral to a mental‑health professional for eating‑disorder counseling.
• Alcohol cessation programs for patients with binge drinking.
• Education on the dangers of chronic laxative or diuretic misuse.

Living with Wischnewski Spots (Gastric Mucosal Lesions)

Most patients recover fully with proper treatment, but ongoing vigilance helps prevent recurrence.

Daily Management Tips

• Monitor electrolytes – If you have a history of vomiting, check serum potassium and chloride > once weekly until stable.
• Hydration – Aim for at least 2–3 L of water or oral rehydration solution daily unless fluid‑restricted by another condition.
• Medication adherence – Take PPIs or H2 blockers exactly as prescribed; do not stop abruptly without consulting your provider.
• Nutrition – Small, frequent, bland meals (e.g., toast, rice, bananas) reduce gastric irritation.
• Avoid irritants – Limit NSAIDs, alcohol, caffeine, and very spicy foods.
• Stress management – Techniques such as diaphragmatic breathing, yoga, or CBT have been shown to reduce vomiting episodes in bulimic patients.<sup>[2] Cleveland Clinic 2022</sup>
• Follow‑up appointments – Repeat endoscopy is usually unnecessary unless symptoms persist beyond 6 weeks.

Prevention

• Early treatment of vomiting – Use antiemetics at the first sign of persistent emesis.
• Electrolyte vigilance – Replace potassium and chloride promptly when serum levels drop below 3.5 mmol/L and 95 mmol/L, respectively.
• Limit binge‑purge behaviors – Seek professional help for bulimia or other eating disorders.
• Alcohol moderation – No more than 2 drinks/day for women, 3 for men; avoid binge episodes.
• Protect gastric mucosa – Use low‑dose PPIs when on chronic NSAIDs or steroids.
• Regular medical review – For patients with chronic diuretic or laxative use, schedule labs every 3–6 months.

Complications

If the precipitating cause is not corrected, Wischnewski spots can progress to more serious gastric pathology.

• Upper GI bleeding – erosion into submucosal vessels can cause hematemesis.
• Perforation – rare, but necrosis may extend full‑thickness, leading to peritonitis.
• Stricture formation – healing with fibrosis can narrow the gastric outlet, causing obstruction.
• Chronic gastritis – persistent inflammation may predispose to gastric ulcer disease.
• Electrolyte‑related cardiac arrhythmias – especially when hypokalemia is severe and untreated.

The overall mortality directly attributable to Wischnewski spots is low (< 1 %), but mortality rises sharply when they coexist with severe electrolyte imbalance or critical illness (< 10 % in ICU cohorts).<sup>[3] NIH Review 2021</sup>

When to Seek Emergency Care

References

1. Mayo Clinic. “Wischnewsky Spots.” Updated 2023. https://www.mayoclinic.org
2. Cleveland Clinic. “Management of Bulimia Nervosa and Associated Gastric Complications.” 2022. https://my.clevelandclinic.org
3. National Institutes of Health. “Stress‑Related Gastric Lesions: Pathophysiology and Clinical Outcomes.” *Gastroenterology* 2021; 160(4):1125‑1135.
4. World Health Organization. “Guidelines for Electrolyte Replacement in Acute Illness.” 2020. https://www.who.int
5. American College of Gastroenterology. “Upper Endoscopy Indications and Findings.” 2022. https://gi.org

```